Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P090022/S047

Softec HD; Softec I; Softec HDO; Softec HDM

Lenstec, Inc. · Decision date Dec 4, 2025

FDA DECISIONP090022/S047

What did the FDA approve?

FDA records P090022/S047 as a supplement to PMA P090022, with the supplement type “Normal 180 Day Track”. The recorded decision is approval, dated Dec 4, 2025.

FDA approval order statement

approval for a different material vial stopper from an alternate supplier.
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track
Clinical specialty
Ophthalmic
Decision date
Dec 4, 2025
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P090022/S047
Regulatory pathway
PMA supplement
Applicant
Lenstec, Inc.
Product code
HQL
Decision code
APPR
Decision date
Dec 4, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: intraocular lens.

Applicant
Lenstec, Inc.
Product code
HQL
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P090022/S046 · Related supplement

    Softec HD; Softec I; Softec HD PS; Softec HDO; Softec HDM

  2. P090022/S047 received

    Application receipt date recorded by FDA.

  3. P090022/S047 · FDA decision

    Normal 180 Day Track

  4. P090022/S049 · Related supplement

    Softec HD; Softec I; Softec HD PS; Softec HDO; Softec HDM

Timeline entries are records held by MedtechLedger for P090022. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P090022

Product / regulatory recordCompanyPathwayDecision dateSource
Lenstec, Inc.PMA supplementAug 12, 2025FDA
Lenstec, Inc.PMA supplementApr 15, 2026FDA

Explore the linked device profile

Other records with product code HQL

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Lenstec, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
1765 Commerce Ave. N, St. Petersburg, FL, 33716

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records